神経修復及び再生の世界市場2019-2026:手術別、製品別、セグメント予測

【英語タイトル】Nerve Repair And Regeneration Market Size, Share & Trends Analysis Report By Surgery (Nerve Grafting, Neurorrhaphy), By Product (Biomaterials Neurostimulation & Neuromodulation Device), And Segment Forecasts, 2019 - 2026

Grand View Researchが出版した調査資料(GV9NV062)・商品コード:GV9NV062
・発行会社(調査会社):Grand View Research
・発行日:2019年6月
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥939,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、神経修復及び再生の世界市場について調査・分析し、市場動向、製品別(バイオシミラー、神経刺激および神経調節デバイス)分析、手術別(直接神経修復/神経移植、神経移植、幹細胞療法、神経刺激および神経調節手術)分析、地域別分析、競合分析などを含め次の構成でお届け致します。

・調査手法及び範囲
・エグゼクティブサマリー
・市場動向
・神経修復及び再生の世界市場:製品別(バイオシミラー、神経刺激および神経調節デバイス)
・神経修復及び再生の世界市場:手術別(直接神経修復/神経移植、神経移植、幹細胞療法、神経刺激および神経調節手術)
・神経修復及び再生の世界市場:地域別
・競合分析
【レポートの概要】

The global nerve repair and regeneration market size is expected to reach USD 17.8 billion by 2026 registering a CAGR of 10.7%, according to a new report by Grand View Research, Inc. Demand for neurological disorder therapies owing to increasing incidence and rising awareness about the same will drive the market. Moreover, government funding and reimbursement policies and uninterrupted technological advances are also projected to help boost the market growth.

In January 2016, the EU Horizon 2020 program funded a research project ‘Autostem’, launched by the NUI Galway’s Regenerative Medicine Institute (REMEDI), costing about USD 6.73 million. This project was to develop a robotic stem cell production factory, having an edge over the old traditional techniques. This technique offers prospects of new therapies for a range of diseases, such as cancers, diabetes, and arthritis. Increased R&D and investments by key companies in emerging countries are also driving the market growth. In July 2018, the Stem Cells Australia (SCA) received USD 3 million for stem cell research from the Medical Research Future Fund (MRFF).

In addition, government and private funded organizations are conducting clinical trials to develop a safe and effective therapy for different neurological disorders, such as Stem Cells in Umbilical Blood Infusion for Cerebral Palsy (Phase II) and usage of Polyethylene glycol (PEG) drug (Phase I) to promote axonal fusion technique to repair peripheral nerve injuries in humans.

Furthermore, in October 2017, Stryker Corporation acquired VEXIM, a France-based medical device company. VEXIM’s portfolio is complementary to Stryker’s Interventional Spine (IVS) portfolio. With this acquisition, Stryker will strengthen its distribution channels in Eastern Europe, Middle East, Asia, and Latin America. In January 2018, Boston Scientific Corporation received U.S. FDA approval for the first and only Spectra WaveWriter spinal cord stimulator system. This system is used for paresthesia-based therapy.

Further key findings from the study suggest:

• In 2018, neuromodulation and neurostimulation devices segment led the market due to increased cases of Central Nervous System (CNS) disorders and awareness about mental disorders and available treatments

• Biomaterials is anticipated to expand at the fastest CAGR during the forecast period due to technological advancements and development of biodegradable polymers that can help enhance spinal stabilization, healing of fractures, and reduce hospitalization

• North America led the market in 2018 owing to technological advancements and advent of new devices. Government initiatives and funding and increased cases of injured CNS, such as injuries to the spinal cord and brain, were some of the major reasons responsible for the region’s growth

• Asia Pacific is expected to be the fastest-growing market during the forecast period. Growing geriatric population, technological advancements, and many unmet medical needs are some of the factors driving the region’s growth

• In February 2016, Indian scientists working for Revita Life Sciences were approved to conduct clinical trials in 20 clinically dead patients to bring specific parts of their CNS back to life

• Combination of therapies including cocktail of peptides, nerve stimulation techniques, injecting the brain with stem cells and other techniques that were successful in bringing patients out of coma were to be used

• Existing medical devices were combined with regenerative biological medicines with an objective to achieve such a complex initiative

• Some of the key companies include Boston Scientific, Inc.; Stryker Corporation; St. Jude Medical, Inc.; Medtronic plc.; Baxter International, Inc.; AxoGen, Inc.; Polyganics B.V.; Integra; Cyberonics, Inc.; and Lifesciences Corporation

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (model 2)
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective – 1:
1.9.2 Objective – 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage outlook
3.1.1 Parent Market Outlook
3.2 Market Segmentation
3.3 Penetration & Growth Prospect Mapping
3.3.1 Penetration & Growth Prospect Mapping
3.4 Regulatory Framework & Reimbursement Scenario
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increasing government fundings and reimbursements
3.5.1.2 Increasing incidences of the neurological disorders
3.5.1.3 Rising medical tourism
3.5.2 Market Restraint Analysis
3.5.2.1 Lack of awareness in the patients for treatment of nerve repair and regeneration
3.5.2.2 High cost of the treatment and unavailability of trained medical personnel
3.6 Business Environment Analysis Tools
3.6.1 Porter’s Five Forces Analysis
3.6.1.1 Bargaining power of buyers:Moderate
3.6.1.2 Bargaining power of suppliers: Low
3.6.1.3 Competitive rivalry: High
3.6.1.4 Threat of new entrants: Moderate
3.6.1.5 Threat of substitutes: Moderate
3.6.2 PESTEL Analysis
3.6.2.1 Political & legal landscape
3.6.2.2 Economic landscape
3.6.2.3 Social landscape
3.6.2.4 Technological landscape
3.6.2.5 Environmental landscape
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Mergers & Acquisitions
3.7.2 Licensing & Partnership
Chapter 4 Nerve Repair And Regeneration Market: Product Analysis
4.1 Nerve Repair And Regeneration Product Market Share Analysis, 2018 & 2026
4.2 Nerve Repair And Regeneration Product Market: Segment Dashboard:
4.3 Market Size & Forecasts And Trend Analyses, 2015 To 2026 For The Product Segment
4.3.1 Biosimilars
4.3.1.1 Biosimilars market, 2015 – 2026 (USD Million)
4.3.2 Neurostimulation & Neuromodulation Devices
4.3.2.1 Spinal cord stimulation devices market, 2015 – 2026 (USD Million)
4.3.2.2. Deep brain stimulation devices market, 2015 – 2026 (USD Million)
4.3.2.3 Sacral nerve stimulation devices market, 2015 – 2026 (USD Million)
4.3.2.4 Vagus nerve stimulation devices market, 2015 – 2026 (USD Million)
4.3.2.5 Gastric electric stimulation devices market, 2015 – 2026 (USD Million)
Chapter 5 Nerve Repair And Regeneration Market: Surgery Analysis
5.1 Nerve Repair And Regeneration Surgery Market Share Analysis, 2018 & 2026
5.2 Nerve Repair And Regeneration Surgery Market: Segment Dashboard
5.3 Market Size & Forecasts And Trend Analyses, 2014 To 2026 For The Surgery
5.3.1 Direct Nerve Repair/Neurorrhaphy
5.3.1.1 Direct nerve repair/Neurorrhaphy market, 2015 – 2026 (USD Million)
5.3.2 Nerve Grafting
5.3.2.1 Nerve grafting market, 2015 – 2026 (USD Million)
5.3.3 Stem Cell Therapy
5.3.3.1 Stem cell therapy market, 2015 – 2026 (USD Million)
5.3.4 Neurostimulation & Neuromodulation Surgeries
5.3.4.1 Neurostimulation & neuromodulation surgeries market, 2015 – 2026 (USD Million)
Chapter 6 Nerve Repair And Regeneration Market: Regional Analysis
6.1 Nerve Repair And Regeneration Regional Market Share Analysis, 2018 & 2026
6.2 Nerve Repair And Regeneration Regional Market: Segment Dashboard
6.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
6.4 List of Players at Regional Level
6.4.1 North America
6.4.2 Europe
6.4.3 Asia Pacific
6.4.4 Latin America
6.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.6 Market Size, & Forecasts, And Trend Analysis, 2014 to 2026
6.6.1 North America
6.6.2 North America Nerve Repair And Regeneration Market, 2015 – 2026 (USD Million)
6.6.2.1 U.S.
6.6.2.2 Canada
6.7 Europe
6.7.1 Europe Nerve Repair And Regeneration Market, 2015 – 2026 (USD Million)
6.7.1.1 U.K.
6.7.1.2. Germany
6.7.1.3 France
6.7.1.4. Italy
6.7.1.5 Spain
6.8 Asia Pacific
6.8.1 Asia Pacific Nerve Repair And Regeneration Market, 2015 – 2026 (USD Million)
6.8.1.1 Japan
6.8.1.2 China
6.8.1.3 India
6.8.1.4 Australia
6.8.1.5 South Korea
6.9 Latin America
6.9.1 Latin America Nerve Repair And Regeneration Market, 2015 – 2026 (USD Million)
6.9.1.1 Brazil
6.9.1.2 Mexico
6.9.1.3 Colombia
6.10 Middle East and Africa
6.10.1 MEA Nerve Repair And Regeneration Market, 2015 – 2026 (USD Million)
6.10.1.1 UAE
6.10.1.2 Saudi Arabia
6.10.1.3 South Africa
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Strategic Framework/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players
7.3 Vendor Landscape
7.4 Public Companies
7.4.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
7.5 Private Companies
7.5.1 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
7.6 Company Profiles
7.6.1 CYBERONICS, INC
7.6.1.1 Company overview
7.6.1.2 Financial performance
7.6.1.3 Product benchmarking
7.6.1.4 Strategic initiatives
7.6.1.5 SWOT Analysis
7.6.2 MEDTRONIC
7.6.2.1 Company overview
7.6.2.2 Financial performance
7.6.2.3 Product benchmarking
7.6.2.4 Strategic initiatives
7.6.2.5 SWOT Analysis
7.6.3 STRYKER
7.6.3.1 Company overview
7.6.3.2 Financial performance
7.6.3.3 Product benchmarking
7.6.3.4 Strategic initiatives
7.6.3.5 SWOT Analysis
7.6.4 AXOGEN CORPORATION
7.6.4.1 Company overview
7.6.4.2 Financial performance
7.6.4.3 Product benchmarking
7.6.4.4 Strategic initiatives
7.6.4.5 SWOT Analysis
7.6.5 ST. JUDE MEDICAL
7.6.5.1 Company overview
7.6.5.2 Financial performance
7.6.5.3 Product benchmarking
7.6.5.4 Strategic initiatives
7.6.5.5 SWOT Analysis
7.6.6 BAXTER
7.6.6.1 Company overview
7.6.6.2 Financial performance
7.6.6.3 Product benchmarking
7.6.6.4 Strategic initiatives
7.6.6.5 SWOT Analysis
7.6.7 BOSTON SCIENTIFIC CORPORATION
7.6.7.1 Company overview
7.6.7.2 Financial performance
7.6.7.3 Product benchmarking
7.6.7.4 Strategic initiatives
7.6.7.5 SWOT Analysis
7.6.8 POLYGANICS
7.6.8.1 Company overview
7.6.8.2 Financial performance
7.6.8.3 Product benchmarking
7.6.8.4 Strategic initiatives
7.6.9 INTEGRA LIFESCIENCES
7.6.9.1 Company overview
7.6.9.2 Financial performance
7.6.9.3 Product benchmarking
7.6.9.4 Strategic initiatives
7.6.9.5 SWOT Analysis

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of Abbreviation
TABLE 3 List of players in North America
TABLE 4 List of players in Europe
TABLE 5 List of players in Asia Pacific
TABLE 6 List of players in Latin America
TABLE 7 List of players in MEA
TABLE 8 North America nerve repair and regeneration market, by country, 2015 - 2026 (USD Million)
TABLE 9 North America nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
TABLE 10 North America nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 11 North America nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 12 U.S. nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 13 U.S. nerve repair and regeneration market, by eurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 14 U.S. nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 15 Canada. nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
TABLE 16 Canada. nerve repair and regeneration market, by neurostimulation and neuromodulation devices 2015 - 2026 (USD Million)
TABLE 17 Canada nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 18 Europe nerve repair and regeneration market, by country, 2015 - 2026 (USD Million)
TABLE 19 Europe nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 20 Europe nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 21 Europe nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 22 U.K. nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 23 U.K. nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 24 U.K. nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 25 Germany nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
TABLE 26 Germany nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 27 Germany nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 28 France nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
TABLE 29 France nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 30 France nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 31 Italy nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
TABLE 32 Italy nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 33 Italy nerve repair and regeneration Market, by surgery, 2015 - 2026 (USD Million)
TABLE 34 Spain nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
TABLE 35 Spain nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 36 Spain nerve repair and regeneration Market, by surgery, 2015 - 2026 (USD Million)
TABLE 37 Asia Pacific nerve repair and regeneration market, by country, 2015 - 2026 (USD Million)
TABLE 38 Asia Pacific nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 39 Asia Pacific nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 40 Asia Pacific nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 41 Japan nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 42 Japan nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 43 Japan nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 44 China nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 45 China nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 46 China nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 47 India nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
TABLE 48 India nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 49 India nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 50 Australia nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 51 Australia nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 52 Australia nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 53 South Korea nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 54 South Korea nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 55 South Korea nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 56 Latin America nerve repair and regeneration market, by country, 2015 - 2026 (USD Million)
TABLE 57 Latin America nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
TABLE 58 Latin America nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 59 Latin America nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 60 Brazil nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 61 Brazil nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 62 Brazil. nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 63 Mexico nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 64 Mexico nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 65 Mexico nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 66 MEA nerve repair and regeneration market, by country, 2015 - 2026 (USD Million)
TABLE 67 MEA nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 68 MEA nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 69 MEA nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 70 South Africa nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 71 South Africa nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 72 South Africa nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 73 UAE nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 74 UAE nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 75 UAE nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
TABLE 76 Saudi Arabia nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
TABLE 77 Saudi Arabia nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
TABLE 78 Saudi Arabia. Nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)


【レポートのキーワード】

神経修復及び再生、バイオシミラー、神経刺激および神経調節デバイス、直接神経修復/神経移植、神経移植、幹細胞療法、神経刺激および神経調節手術

★調査レポート[神経修復及び再生の世界市場2019-2026:手術別、製品別、セグメント予測] (コード:GV9NV062)販売に関する免責事項を必ずご確認ください。
★調査レポート[神経修復及び再生の世界市場2019-2026:手術別、製品別、セグメント予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆